Henderson Global Investors BV, a subsidiary of Henderson Group plc, is a prominent independent global asset management firm established in 1934. Headquartered in London, the company manages a diverse portfolio of assets, providing investment services to institutional, retail, and high-net-worth clients. Henderson offers a wide range of investment products across various asset classes, including equities, fixed income, private equity, property, and alternative investments. With a significant presence in Europe, North America, and Asia, the firm operates offices in key financial centers such as Amsterdam, Boston, and Singapore. As one of Europe's largest investment managers, Henderson employs approximately 1,000 professionals and manages a substantial amount of assets. The firm's investment strategies are supported by a dedicated team of researchers and economists, ensuring that investment decisions are informed by thorough market analysis and a robust risk-control framework.
Simba Sleep is a London-based company that specializes in designing and manufacturing mattresses, pillows, duvets, bedding, and bed bases. Founded in 2015, the company combines innovative materials such as precision-engineered foam and patented conical pocket springs to create a range of mattresses that promote comfortable sleep. Simba Sleep emphasizes the importance of quality rest in daily life, aiming to help customers improve their sleep experience. Its products are available for purchase online and in select retail locations, including John Lewis stores in the United Kingdom. Additionally, Simba Sleep offers financing options for customers looking to invest in better sleep.
Simba Sleep is a London-based company that specializes in designing and manufacturing mattresses, pillows, duvets, bedding, and bed bases. Founded in 2015, the company combines innovative materials such as precision-engineered foam and patented conical pocket springs to create a range of mattresses that promote comfortable sleep. Simba Sleep emphasizes the importance of quality rest in daily life, aiming to help customers improve their sleep experience. Its products are available for purchase online and in select retail locations, including John Lewis stores in the United Kingdom. Additionally, Simba Sleep offers financing options for customers looking to invest in better sleep.
Verona Pharma is a clinical-stage biopharmaceutical company based in London, established in 2005. The company specializes in developing and commercializing therapies for respiratory diseases that have significant unmet medical needs, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. Its lead product candidate, ensifentrine, is an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, functioning as both a bronchodilator and an anti-inflammatory agent. Ensifentrine is being developed in various formulations, including nebulized, dry powder inhaler, and pressurized metered-dose inhaler, with the nebulized form currently in Phase 2b clinical development for the maintenance treatment of COPD. Verona Pharma's commitment is to enhance the health and quality of life for individuals suffering from chronic respiratory conditions through innovative therapeutic solutions.
Gartmore Investment Limited is a privately owned hedge fund sponsor based in London, United Kingdom. Established in 1969, the firm specializes in asset management, providing a diverse range of investment products and services designed to meet the needs of both retail and institutional clients. As a respected independent fund manager, Gartmore focuses exclusively on managing hedge funds for its clients, ensuring tailored solutions that align with their investment goals. The firm operates under the auspices of Henderson Global Investors Limited, reflecting its commitment to delivering high-quality investment management services.
New Star Asset Management
Acquisition in 2009
New Star Asset Management is an investment management holding company. The company through its subsidiaries provides services in areas including UK investment funds, investment trusts, offshore funds/SICAVs, alternative investments, and Specialist institutional funds.
Alaunos Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for cancer, specifically through adoptive TCR-T cell therapy. The company utilizes a unique gene expression and control technology to deliver DNA that targets neoantigens derived from genomic mutations in solid tumors. This approach aims to enhance the immune response against cancer cells. Alaunos is currently conducting Phase 2 clinical studies to evaluate the efficacy of its therapies, including the immune system cytokine interleukin-12 for breast cancer and advanced melanoma. Additionally, the company is exploring multiple investigational new drug applications for new therapeutic targets, leveraging its advanced technology to improve treatment outcomes for patients.
Alaunos Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for cancer, specifically through adoptive TCR-T cell therapy. The company utilizes a unique gene expression and control technology to deliver DNA that targets neoantigens derived from genomic mutations in solid tumors. This approach aims to enhance the immune response against cancer cells. Alaunos is currently conducting Phase 2 clinical studies to evaluate the efficacy of its therapies, including the immune system cytokine interleukin-12 for breast cancer and advanced melanoma. Additionally, the company is exploring multiple investigational new drug applications for new therapeutic targets, leveraging its advanced technology to improve treatment outcomes for patients.
Homann Feinkost GmbH, established in 1876 and headquartered in Dissen, Germany, specializes in the production of chilled food products. The company offers a diverse range of items, including bread and dip, mayonnaise, salad dressings, and seafood salads. As of April 2015, it operates as a subsidiary of Gastronomia y Negocios S.A. Homann Feinkost aims to provide convenient and flavorful options suitable for various occasions, such as grilling, snacking, or enhancing meals.
Wellnet SpA
Acquisition in 2004
Italian fitness and wellness chain
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.